West Highlights Rigid Needle Shields for Prefilled Syringes

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, provided more information on its product offering, the Rigid Needle Shield (RNS), at the Parenteral Drug Association (PDA) Europe Annual Meeting. Designed to provide added safety for prefilled syringes with a staked needle, the West RNS helps ensure the integrity of injectable drug products. The West RNS was showcased June 13-14, 2017, at the PDA Europe Annual Meeting in Berlin, Germany along with West’s comprehensive product portfolio and technical insights.

“Pharmaceutical companies continue to look for drug packaging and delivery solutions that offer safety, efficiency, and an improved experience for patients and care providers alike,” said Mike Schaefers, VP, Global Product Management and Marketing Operations, West. “As a trusted partner to the world’s top pharmaceutical and biotechnology companies, West understands the important role that component and delivery system technologies play in helping to improve patient outcomes. We’re proud to provide the West RNS as an offering that helps support the safe, effective delivery of injectable medicines to patients around the world.”

The West RNS helps preserve and protect the integrity of injectable drug products and provides added safety for ISO prefilled syringes with a staked needle. Manufactured from best-in-class elastomers especially designed for prefilled applications, the West RNS combines the sealing properties of soft rubber shields with the rigidity of a medical-grade polypropylene cover. It safeguards against needle tip damage and deformation when removing a rigid needle shield from a prefilled syringe, and offers a comfortable design for healthcare providers and patients to help ensure proper de-shielding. Additionally, the West RNS is designed for easy distribution and orientation on syringe assembly lines from different vendors, offering flexibility for pharmaceutical manufacturers.

In addition to the West RNS, the company had several high-value drug delivery system and packaging component technologies on display at the PDA Europe Annual Meeting, including:

SmartDose^® platform – A wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.

NovaPure^® components – High-quality components for higher-volume pre-filled delivery systems designed using Quality by Design (QbD) principles to reduce particulate and ensure consistency of delivery.

NovaGuard^® SA Pro safety system – Aids in the protection of healthcare professionals, patients, and care providers from accidental needlesticks.

Daikyo Crystal Zenith^® cyclic olefin polymer – A high-performance alternative to glass and an integrated lifecycle solution for containment and delivery systems designed to help maintain drug safety, purity, and efficacy from development through to commercialization.

Daikyo RUV^® & Daikyo RSV^® components – Manufactured using clean, high-quality elastomer formulations.

About West

West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world’s pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West’s 2016 net sales of $1.5 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world. For more information on West products and services, visit www.westpharma.com.

West, the diamond logo, the By your side for a healthier world™, NovaGuard® SA Pro, and NovaPure® are registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.

SmartDose® is a registered trademark of Medimop Medical Projects Ltd., a subsidiary of West Pharmaceutical Services, Inc. West seeks partners for its SmartDose drug delivery technology platform. This platform is intended to be used as an integrated system with drug filling and final assembly completed by the pharmaceutical/biotechnology company.

Daikyo Crystal Zenith®, Daikyo RSV®, and Daikyo RUV® are registered trademarks of Daikyo Seiko, Ltd. Daikyo Crystal Zenith technology is licensed from Daikyo Seiko, Ltd.